Corrigendum to “Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse" [Journal of Substance Abuse Treatment 131 (2021) 108447]

Miranda G. Greiner, Matisyahu Shulman, Tse Hwei Choo, Jennifer Scodes, Martina Pavlicova, Aimee N.C. Campbell, Patricia Novo, Marc Fishman, Joshua D. Lee, John Rotrosen, Edward V. Nunes

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that there is an error in the current manuscript publication in the Methods section under “2.1 Design Overview” when describing the detoxification procedures at the inpatient units. The text currently reads: “Detoxification approaches varied between the 8 sites (3 sites used buprenorphine tapers, 4 sites used methadone tapers, and 2 used no opioids and provided only clonidine and non-opioid medications).” The corrected text should read: “Detoxification approaches varied between the sites (two sites used buprenorphine tapers, four sites used methadone tapers, and two used no opioids and provided only clonidine and non-opioid medications).” The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Article number108566
JournalJournal of Substance Abuse Treatment
Volume136
DOIs
StatePublished - May 2022

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Corrigendum to “Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse" [Journal of Substance Abuse Treatment 131 (2021) 108447]'. Together they form a unique fingerprint.

Cite this